PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with (18)F-AV-133 (florbenazine) in patients with Alzheimer’s disease and Lewy body disorders

BACKGROUND: Biomarkers based on the underlying pathology of Alzheimer’s disease (AD) and Dementia with Lewy Bodies (DLB) have the potential to improve diagnosis and understanding of the substrate for cognitive impairment in these disorders. The objective of this study was to compare the patterns of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Siderowf, Andrew, Pontecorvo, Michael J, Shill, Holly A, Mintun, Mark A, Arora, Anupa, Joshi, Abhinay D, Lu, Ming, Adler, Charles H, Galasko, Douglas, Liebsack, Carolyn, Skovronsky, Daniel M, Sabbagh, Marwan N
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2014
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4027995/
https://ncbi.nlm.nih.gov/pubmed/24716655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-14-79
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi